Nathan Jorgensen
2021
In 2021, Nathan Jorgensen earned a total compensation of $539.4K as Chief Financial Officer at Vor Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $138,550 |
|---|---|
| Salary | $382,902 |
| Other | $17,915 |
| Total | $539,367 |
Jorgensen received $382.9K in salary, accounting for 71% of the total pay in 2021.
Jorgensen also received $138.6K in non-equity incentive plan and $17.9K in other compensation.
Rankings
In 2021, Nathan Jorgensen's compensation ranked 10,562nd out of 12,415 executives tracked by ExecPay. In other words, Jorgensen earned more than 14.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,562 out of 12,415 | 15th |
Division Manufacturing | 4,668 out of 5,505 | 15th |
Major group Chemicals And Allied Products | 2,098 out of 2,375 | 12th |
Industry group Drugs | 1,862 out of 2,096 | 11th |
Industry Biological Products, Except Diagnostic Substances | 409 out of 449 | 9th |
Source: SEC filing on April 14, 2023.
Jorgensen's colleagues
We found three more compensation records of executives who worked with Nathan Jorgensen at Vor Biopharma in 2021.